| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/16/1991 | WO1991006571A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 05/16/1991 | WO1991006562A1 Immunological domains of hepatitis delta virus antigen |
| 05/16/1991 | WO1991006321A1 Use of honey as vaccine |
| 05/16/1991 | WO1991006319A1 Methods and compositions for promoting immunopotentiation |
| 05/16/1991 | WO1991006311A1 Anti-viral material |
| 05/16/1991 | WO1991006306A1 Antivenoms and methods for making antivenoms |
| 05/16/1991 | CA2072657A1 Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms |
| 05/16/1991 | CA2071546A1 Anti-viral material |
| 05/16/1991 | CA2071478A1 Methods and compositions for promoting immunopotentiation |
| 05/16/1991 | CA2045184A1 Pneumocystis carinii dihydrofolate reductase gene and methods for its use |
| 05/15/1991 | EP0427462A1 Process |
| 05/15/1991 | EP0427399A1 Cancer marker and monoclonal antibodies specific therefor |
| 05/15/1991 | EP0427347A1 Synthetic peptides useful as universal carriers for the preparation of immunogenic conjugates and their use in the development of synthetic vaccines |
| 05/15/1991 | EP0426913A1 Pharmaceutical composition and method for the suppression of factor VIII inhibitor production |
| 05/15/1991 | EP0426838A1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
| 05/15/1991 | EP0426787A1 POLYPEPTIDE RESULTING FROM THE FUSION BETWEEN A MALTOSE-RELATED COMPOUND (MalE) AND A CD4 FRAGMENT FOR NEUTRALIZING THE AIDS VIRUS |
| 05/15/1991 | CN1051393A Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
| 05/15/1991 | CN1051389A Novel antibodies reactive with human carcinomas |
| 05/15/1991 | CA2029714A1 Antiidiotypic monoclonal antibodies |
| 05/14/1991 | WO1991007494A1 Chimeric mouse human antibodies with specificity to hiv antigens |
| 05/14/1991 | WO1991007482A1 Type-b rotavirus cultures and uses thereof |
| 05/14/1991 | WO1991007434A1 Control of milk secretion |
| 05/14/1991 | WO1991007418A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
| 05/14/1991 | WO1991007182A1 rRNA SPECIFIC OLIGONUCLEOTIDES |
| 05/14/1991 | CA2068520A1 Type-b rotavirus cultures and uses thereof |
| 05/14/1991 | CA2068515A1 Control of milk secretion |
| 05/14/1991 | CA2068325A1 Rrna specific oligonucleotides |
| 05/14/1991 | CA2044627A1 Chimeric mouse human antibodies with specificity to hiv antigens |
| 05/14/1991 | CA2044609A1 Chimeric mouse human antibodies with specificity to hiv antigens |
| 05/14/1991 | CA2044590A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
| 05/10/1991 | WO1991007438A1 A method for isolating factor viii |
| 05/08/1991 | WO1991006305A1 Oligomeric immunoglobulins |
| 05/08/1991 | EP0426314A2 HIV related peptides |
| 05/08/1991 | EP0426059A1 Promoter regions of the genes which code for the pilinic subunits fim2, fim3 and fimx of Bordetella pertussis and their use for the expression of genes which code for a protein of interest |
| 05/08/1991 | EP0425536A1 Nonglycosylated human interleukin-3 compositions |
| 05/08/1991 | CA2045150A1 Oligomeric immunoglobulins |
| 05/07/1991 | US5013663 Canine corona virus vaccine |
| 05/07/1991 | US5013661 Lipopolysaccharide-specific acyloxyacyl hydrolase |
| 05/07/1991 | US5013556 Lipids derivatized with polyoxyethylene glycol, drug delivery, antitumor agents |
| 05/07/1991 | US5013555 Agent for desensitizing man and/or animals against an allergen |
| 05/07/1991 | US5013548 Vaccines against AIDS |
| 05/07/1991 | US5013445 Liquid chromatography, porous gel solid phase, no adjustment of buffer solution pH |
| 05/07/1991 | CA1283856C Purification of immunoglobulin g |
| 05/04/1991 | WO1991006317A1 Cross-protective salmonella vaccines |
| 05/04/1991 | WO1991006316A1 Reduced-protein subunit vaccine for swine dysentery |
| 05/04/1991 | CA2331088A1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 05/04/1991 | CA2072633A1 Cross-protective salmonella vaccines |
| 05/04/1991 | CA2029146A1 Promoter regions of the genes which code for the pilinic subunits fim2, fim3 and fimx of bordetella pertussis and their use for the expression of genes which code for a protein ofinterest |
| 05/03/1991 | CA2002209A1 Pharmaceutical composition and method for the suppression of factor viii inhibitor production |
| 05/02/1991 | WO1991005871A1 Bispecific heteroantibodies with dual effector functions |
| 05/02/1991 | WO1991005864A1 Production of genetically-engineered vaccines for aids and other retroviral diseases |
| 05/02/1991 | WO1991005567A1 Vaccins for protecting against infections by hiv virus, process for producing the same and their use as diagnostic and immunotherapy means |
| 05/02/1991 | WO1991005559A1 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 05/02/1991 | WO1991004273A3 Novel peptides associated with the cd4 binding region of gp120 and their methods of use |
| 05/02/1991 | EP0425235A2 Cytotoxic agents comprising maytansinoids and their therapeutic use |
| 05/02/1991 | EP0425082A1 Bordetella vaccines |
| 05/02/1991 | EP0424975A2 Artificial carrier for immobilization of biological proteins and process for production thereof |
| 05/02/1991 | EP0424748A1 Synthetic envelope peptides of HTLV-I |
| 05/02/1991 | EP0424519A1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship. |
| 05/02/1991 | EP0424437A1 Recombinant mycobacterial expression vehicles and uses therefor |
| 05/02/1991 | EP0214232B1 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
| 05/01/1991 | WO1991006652A1 Outer membrane protein p1 and peptides of haemophilus influenzae type b |
| 05/01/1991 | WO1991006573A1 Inhibitor of laminin neurite promoting activity |
| 05/01/1991 | WO1991006318A1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 05/01/1991 | CN1050989A Production method of bone-joining drug |
| 05/01/1991 | CN1050987A Stable immunogen composition for oral administration |
| 05/01/1991 | CA2066658A1 Inhibitor of laminin neurite promoting activity |
| 05/01/1991 | CA2027317A1 Vaccine composition with non-immunosuppressive t-cell epitope component |
| 04/30/1991 | US5011915 Centrifuging yeast membrane extract, then diafiltation in guanidine hydrochloride solution, solubilizing with denaturing agent and reducing agent |
| 04/30/1991 | US5011828 Immunostimulating guanine derivatives, compositions and methods |
| 04/30/1991 | US5011684 Administering monoclonal antibody to interleukin receptor |
| 04/30/1991 | CA1283750C Platinum co-ordination compounds |
| 04/30/1991 | CA1283661C Imidazolides, process for their preparation and application as intermediates for the synthesis of cytotoxic conjugates |
| 04/30/1991 | CA1283602C Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 04/28/1991 | WO1991006572A1 Diagnosis of glomerulonephritis |
| 04/28/1991 | WO1991006320A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
| 04/28/1991 | CA2071530A1 Diagnosis of glomerulonephritis |
| 04/28/1991 | CA2071502A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
| 04/28/1991 | CA2028517A1 Enhancement of porcine somatotropin activity |
| 04/25/1991 | WO1991006647A1 Gastrin releasing peptide receptor |
| 04/25/1991 | WO1991006646A1 Solubilization and purification of the gastrin releasing peptide receptor |
| 04/25/1991 | CA2069965A1 Solubilization and purification of the gastrin releasing peptide receptor |
| 04/25/1991 | CA2067766A1 Gastrin releasing peptide receptor |
| 04/24/1991 | WO1991006011A1 Methods for evaluating cholesterol metabolism and reagents therefor |
| 04/24/1991 | EP0424107A1 A novel tumor-associated antigen |
| 04/24/1991 | EP0423869A1 Infectious bronchitis virus vaccine |
| 04/24/1991 | EP0423747A2 Glycosyl-etoposide prodrugs, process for their preparation and their use in combination with functionalised tumour-specific enzyme conjugates |
| 04/24/1991 | EP0423649A1 Peptides and use thereof |
| 04/24/1991 | EP0423317A1 Invasive microorganisms |
| 04/24/1991 | EP0423315A1 Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine |
| 04/24/1991 | EP0423239A1 Post-transfusion, non-a, non-b hepatitis virus and antigens |
| 04/24/1991 | EP0423238A1 Synthetic vaccine against p. falciparum malaria |
| 04/24/1991 | CA2069323A1 Methods for evaluating cholesterol metabolism and reagents therefor |
| 04/24/1991 | CA2028172A1 Synthetic envelope peptides of htlv-i |
| 04/23/1991 | US5010176 Malonate linker |
| 04/23/1991 | US5009888 Increased half-life |
| 04/21/1991 | WO1991005805A1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR |
| 04/21/1991 | WO1991005568A1 Materials and methods for the treatment of foreign tissue |
| 04/21/1991 | WO1991005546A1 Solid tumor treatment method and composition |
| 04/21/1991 | WO1991005545A1 Liposome microreservoir composition and method |